Skip to content
BidBenchmark

Contract award

HEALTH RESEARCH, INC.

LYME DISEASE: B CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION
PIID
75N93019C00040
Award key
CONT_AWD_75N93019C00040_7529_-NONE-_-NONE-
Recipient UEI
G9H6SUM59YC4
Source as of
—
Current award value
$10,279,0053
Obligated to date
$10,279,0052
Potential with options
$10,279,0053
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Menands, New York
Set-aside
No set-aside used
Pricing
Cost No Fee
Competition
Full and Open Competition8 offers received
Period of performance
Sep 16, 2019 — Sep 15, 2025Through Sep 15, 2025 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 13, 2019Initial award$1,660,786.00$10,279,005.10
P00001Feb 14, 2020M$0.00$10,279,005.10
P00002Jul 22, 2020M$0.00$10,279,005.10
P00003Aug 20, 2020G$1,901,409.00$10,279,005.10
P00004Feb 23, 2021M$0.00$10,279,005.10
P00005Aug 2, 2021M$0.00$10,279,005.10
P00006Sep 1, 2021G$1,846,478.00$10,279,005.10
P00007Oct 14, 2021M$0.00$10,279,005.10
P00008Nov 3, 2021M$0.00$10,279,005.10
P00009Feb 11, 2022M$0.00$10,279,005.10
P00010Jun 7, 2022M$0.00$10,279,005.10
P00011Aug 3, 2022B$1,123,255.00$10,279,005.10
P00012Aug 4, 2022G$1,887,202.00$10,279,005.10
P00013Aug 26, 2022M$0.00$10,279,005.10
P00014Nov 1, 2022M$0.00$10,279,005.10
P00015Jan 3, 2023M$0.00$10,279,005.10
P00016Mar 28, 2023M$0.00$10,279,005.10
P00017Jul 3, 2023M$0.00$10,279,005.10
P00018Aug 18, 2023G$1,865,211.00$10,279,005.10
P00019Jan 8, 2024M$0.00$10,279,005.10
P00020Mar 21, 2024M$0.00$10,279,005.10
P00021Jul 11, 2024M$0.00$10,279,005.10
P00022Aug 27, 2024M$0.00$10,279,005.10
P00023Jan 22, 2025M-$5,019.07$10,279,005.10
P00024Sep 1, 2026C-$316.83$10,279,005.10

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.gov—Sep 3, 2026usaspending_contract_csv@2026.08.2b7b121653591
contractor_idUSAspending.gov—Sep 3, 2026usaspending_contract_csv@2026.08.2b7b121653591
current_award_valueUSAspending.gov—Sep 3, 2026usaspending_contract_csv@2026.08.2b7b121653591
naics_codeUSAspending.gov—Sep 3, 2026usaspending_contract_csv@2026.08.2b7b121653591
potential_award_valueUSAspending.gov—Sep 3, 2026usaspending_contract_csv@2026.08.2b7b121653591
psc_codeUSAspending.gov—Sep 3, 2026usaspending_contract_csv@2026.08.2b7b121653591
total_obligatedUSAspending.gov—Sep 3, 2026usaspending_contract_csv@2026.08.2b7b121653591

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 25 transaction records parsed from USAspending.gov, retrieved Sep 3, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
75N93019C00040 — HEALTH RESEARCH, INC. · BidBenchmark